Gilead Sciences
GILD
#129
Rank
C$209.96 B
Marketcap
C$169.22
Share price
-1.14%
Change (1 day)
32.16%
Change (1 year)

Gilead Sciences (GILD) - Cash on Hand

Cash on Hand as of September 2025 : C$10.25 Billion

According to Gilead Sciences's latest financial reports the company has C$10.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Gilead Sciences - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$16.59 B72.29%
2023-12-31C$9.63 B11.2%
2022-12-31C$8.66 B4.27%
2021-12-31C$8.30 B-12.03%
2020-12-31C$9.44 B-70.3%
2019-12-31C$31.80 B-22.4%
2018-12-31C$40.98 B27.8%
2017-12-31C$32.07 B100.64%
2016-12-31C$15.98 B-21.11%
2015-12-31C$20.26 B72.4%
2014-12-31C$11.75 B417.88%
2013-12-31C$2.26 B22.56%
2012-12-31C$1.85 B-81.61%
2011-12-31C$10.07 B380.05%
2010-12-31C$2.09 B20.32%
2009-12-31C$1.74 B-19.9%
2008-12-31C$2.17 B86.16%
2007-12-31C$1.16 B7.19%
2006-12-31C$1.09 B-59.46%
2005-12-31C$2.69 B78.63%
2004-12-31C$1.50 B64.23%
2003-12-31C$0.91 B-38.38%
2002-12-31C$1.48 B60.3%
2001-12-31C$0.92 B20.84%
2000-12-31C$0.76 B80.97%
1999-12-31C$0.42 B173.16%
1998-12-31C$0.15 B239.97%
1997-12-31C$45.72 M-74.71%
1996-12-31C$0.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Amgen
AMGN
C$13.18 B 28.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$8.77 B-14.45%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$7.91 B-22.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$1.78 B-82.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$5.52 B-46.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$20.91 B 103.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$25.91 B 152.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$13.83 B 34.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$25.42 B 147.84%๐Ÿ‡บ๐Ÿ‡ธ USA